| Name | Title | Contact Details |
|---|
County Of Ripley is a Doniphan, MO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Universal Pediatrics is a company that provides in-home healthcare and private duty nursing services for children and young adults with serious medical conditions.
Betz Nursing Home is a Auburn, IN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Since opening its doors in 1957, Southeast Health has provided for the changing healthcare needs of the growing communities it serves which includes about 600,000 residents neighboring communities and counties of Southeast Alabama, Southwest Georgia and the Florida Panhandle. Our progress represents the culmination of distinguished service by dedicated board members, physicians, employees and volunteers, and a supportive community. It takes more than technology and a modern facility to treat people. It takes a team of dedicated, well-trained professionals to continually deliver quality healthcare. Employing about 2,500, Southeast Health is recognized as one of the largest employers in the region and is proud of its reputation of providing a positive and responsive work environment. Southeast Health`s medical staff consists of more than 225 active members and just over 400 total members either board certified or board prepared in specialties representing virtually every area of medicine. Through innovation and sustained performance, Southeast Health, a 420-bed regional referral center, has achieved the reputation of providing the best diagnostic, clinical, surgical and patient care services available in the region.
Bionor Pharma is a leading biotechnology company advancing the first therapeutic vaccine towards a functional cure for HIV. The company`s focus is the research and development of peptide-based vaccines against viral diseases, primarily HIV. Bionor Pharma`s most advanced product candidate is Vacc-4x, which is also the most advanced therapeutic vaccine in the HIV space and has demonstrated a reduction of viral load in a large, randomized, controlled Phase II trial, as well as safety and tolerability. Pharma`s current clinical focus is to explore whether Vacc-4x, used with other medicines as a combination therapy, can reduce the viral load even further, and the company, through collaboration with Celgene, is investigating Vacc-4x and the HDAC inhibitor romidepsin in the REDUC study. In May 2015, Bionor Pharma announced promising results from an interim analysis of Part B of the REDUC study. In the study, Vacc-4x and romidepsin are explored as a possible treatment regimen to reduce the persistent latent viral reservoir in HIV infected patients on anti-retroviral treatment. Results are expected in the second half of 2015. Bionor Pharma is headquartered in Oslo, Norway, with offices in Copenhagen and New York.